GLP-1s are a breakthrough—saving lives by tackling obesity and showing promise for dementia, liver disease, and alcoholism. But let’s be clear: Big Food helped create this crisis, and Big Pharma wants patients on these drugs for life.The real solution is deeper. Microdosing GLP-1s, combined with probiotics, prebiotics, and lifestyle change, can repair the microbiome and create an exit ramp. GLP-1s should be a bridge, not a lifelong dependency